Reset
Showing 2 of 2 academic articles

Cost effectiveness of vildagliptin versus glimepiride as add-on treatment to metformin for the treatment of diabetes mellitus type 2 patients in Greece

Hara Kousoulakou, Magdalini Hatzikou, Varvara Baroutsou, John Yfantopoulos • Cost Effectiveness and Resource Allocation (2017)

Abstract Objectives This study was designed to assess the cost-effectiveness of vildagliptin versus glimepiride as add-on to metformin in the management of type 2 diabetes mellitus (T2DM) patients in the Greek healthcare setting. Methods A ...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12962-017-0082-7